John Dennis

University of Exeter Medical School

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (11)

Jordi Merino

Københavns Universitet

DENMARK

View details

Norman Rosenblum

Paediatric Nephrologist, Senior Scientist, Professor

The Hospital for Sick Children/ University of Toronto

CANADA

View details

Ewan Pearson

Academic, Clinical Professor (Teaching and Research) of Diabetic Medicine

University of Dundee

UNITED KINGDOM

View details

Jack Bowden

Professor

University of Exeter

UNITED KINGDOM

View details

Angus Jones

Associate Clinical Professor

University of Exeter

UNITED KINGDOM

View details

Eiji Yoshihara

Investigator/Assistant Professor

The Lundquist Institute

UNITED STATES

View details

Fiona Warren

Lecturer in Medical Statistics

University of Exeter

UNITED KINGDOM

View details

Ines Barroso

Professor

University of Exeter

UNITED KINGDOM

View details

Feyza Engin

Associate Professor

University of Wisconsin-Madison

UNITED STATES

View details

Svenja Meyhöfer

University of Lübeck

GERMANY

View details

Andrew Hattersley

Professor of Molecular Medicine

University of Exeter

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

John Dennis

Research Interests

Explore related searches

Contact this professor

Articles (20)

Recognising, quantifying and accounting for classification uncertainty in type 2 diabetes subtypes

Evaluating prediction of short‐term tolerability of five type 2 diabetes drug classes using routine clinical features: UK population‐based study

Safety and effectiveness of SGLT2 inhibitors in a UK population with type 2 diabetes and aged over 70 years: an instrumental variable approach

Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes

Reporting guidelines for precision medicine research of clinical relevance

Comment on Garvey et al. Association of Baseline Factors With Glycemic Outcomes in GRADE: A Comparative Effectiveness Randomized Clinical Trial. Diabetes Care 2024;47:562–570

Challenges of detecting childhood diabetes in primary care

Dirichlet process mixture models to impute missing predictor data in counterfactual prediction models: an application to predict optimal type 2 diabetes therapy

Risk factor associations for severe COVID-19, influenza and pneumonia in people with diabetes to inform future pandemic preparations: UK population-based cohort study

Patient stratification for determining optimal second-line and third-line therapy for type 2 diabetes: the TriMaster study

Correction to: The impact of population-level HbA1c screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis

HbA1c screening for the diagnosis of diabetes. Reply to Brož J, Brabec M, Krollová P et al [letter]

The impact of population-level HbA1c screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis

Identifying type 1 and 2 diabetes in research datasets where classification biomarkers are unavailable: assessing the accuracy of published approaches

Recent UK type 2 diabetes treatment guidance represents a near whole population indication for SGLT2-inhibitor therapy

Development of a treatment selection algorithm for SGLT2 and DPP-4 inhibitor therapies in people with type 2 diabetes: a retrospective cohort study.

Heterogeneity in phenotype, disease progression and drug response in type 2 diabetes.

Correction to: DR15-DQ6 remains dominantly protective against type 1 diabetes throughout the first five decades of life

Trends in 28-Day Mortality of Critical Care Patients With Coronavirus Disease 2019 in the United Kingdom: A National Cohort Study, March 2020 to January 2021.

Collaborators (11)

Jordi Merino

Norman Rosenblum

Ewan Pearson

Jack Bowden

Angus Jones

Eiji Yoshihara

Fiona Warren

Ines Barroso

Feyza Engin

Svenja Meyhöfer

Andrew Hattersley

Make your next move.